Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.
Pfizer has been going through a period of transition.
Pfizer's stock price has plummeted by 34% over the past five years, leading to a 6% dividend yield that has caught the attention of investors seeking high yields. While a high dividend yield may seem attractive, a falling stock price often indicates underlying business troubles. Pfizer has been grappling with declining demand for its coronavirus products and losing exclusivity on several blockbuster drugs.
The company implemented a cost realignment plan, which was a positive development, but such measures typically require time and may not guarantee success in achieving key goals.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
